Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitetearscience.com
CategoryMedical
Phone(919) 467-4007
Employees
Founded2005

Offices

Morrisville, USA
5151 McCrimmon Parkway
Suite 250
Morrisville, NC, 27560
USA

People

CFO
SVP - European Region
VP, Research & Development
VP, Clinical & Regulatory
Board of Directors
Board of Directors
Director, Quality Assurance & Regulatory Compliance
CTO & Co - Founder
Show All People

Funding

Tags

TearScience

Headquartered in Morrisville, North Carolina, TearScience has pioneered devices that provide significant clinical identification and treatment of evaporative dry eye. Of the 100 million plus of dry eye sufferers worldwide, the leading cause (86percent) is evaporative dry eye, which is caused by Meibomian Gland Dysfunction (MGD) and a lipid deficiency of the eye’s natural tear film. The Tear Film and Ocular Surface Society (TFOS) workshop, involving two years of work by 50 leading experts from around the world, concluded that MGD is an under-estimated condition and is very likely the most frequent cause of dry eye disease. Common symptoms of the disease include eye irritation, dryness, redness, tiredness, and visual disturbances. TearScience’s integrated, in-office system enables eye care professionals to effectively address a root cause of evaporative dry eye.

Recent Milestones

Videos

Screenshots

Sources

  1. TearScience, Inc.: Series C $44.5M (onbiovc.com) [edit]
  2. TearScience Secured up to $70M in Funding from HealthCare Royalty Partners (finsmes.com) [edit]
Edit This Page
Last Edited 11/10/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy